Skip to main content
. 2021 Apr 21;11:8626. doi: 10.1038/s41598-021-88133-7

Figure 3.

Figure 3

Tiliroside restrained the 3D formation ability and CD133 expression of Hep3B and SNU-449 cells. The representative 3D spheroid models of Hep3B (A) and SNU-449 (B) cells treated by 40 μM Tiliroside and NC. The relative cross-section area formation efficiency showed significant reduction of area of Hep3B (C) and SNU-449 (D) in Tiliroside groups. Relative inhibition rates of Hep3B and SNU-449 in response to Tiliroside were calculated by comparing the fluorescence value of Tiliroside to NC, at 24, 48, 72, 96 and 120 h, respectively (E). Tiliroside (40 μM) treatment significantly reduced the CD133 relative expression levels in both 3D cultured Hep3B and SNU-449 cells (P < 0.001) (F). NC negative control.